Reprogramming the microbiome: Anatara Lifesciences targets the human health space with dual targeted formulation
21 OCTOBER 2019 NUTRAingredients
Anatara CEO, Steven Lydeamore, was recently interviewed by NUTRAingredients Editor, Tingmin Koe, about how Anatara’s Gastrointestinal ReProgramming (GaRP) dietary supplement has the ability reduce inflammation, address microbiome dysbiosis and promote mucosal healing. There is a significant unmet medical need for products that can address these factors which contribute to the primary symptoms experienced by patients suffering chronic bowel conditions such as irritable bowel syndrome and the inflammatory bowel diseases.
Click the following link for access to the article – https://www.nutraingredients.com/Article/2019/10/22/Reprogramming-the-microbiome-Anatara-Lifesciences-targets-the-human-health-space-with-dual-targeted-formulation
NutraIngredients has been the leading online news source for the nutrition industry for more than 15 years, providing a 360-degree view of the global functional food and supplement market, spanning everything from investment, incubation and innovation, to ingredients, food science and product formulation, labelling, litigation, regulation, consumer trends, new products and new technology.